No Oestrogen Receptors Found in Pancreatic Cancer
Author Information
Author(s): O.M. Taylor, J. Teasdale, P.N. Cowen, M.J. McMahon, E.A. Benson
Primary Institution: The General Infirmary at Leeds
Hypothesis
Are oestrogen receptors present in pancreatic carcinoma tissue?
Conclusion
The study found no detectable oestrogen receptors in pancreatic carcinoma tissue, suggesting that hormonal manipulation therapy is unlikely to be effective.
Supporting Evidence
- Previous studies suggested the presence of oestrogen receptors in pancreatic carcinoma.
- All biopsies tested were negative for oestrogen receptors using both assay methods.
- The results indicate that hormonal therapies may not be effective for pancreatic cancer.
Takeaway
The researchers looked for special proteins called oestrogen receptors in pancreatic cancer samples but found none, which means hormones probably won't help treat this type of cancer.
Methodology
The study used isoelectric focusing and immunocytochemical assays to test 23 pancreatic carcinoma biopsies for oestrogen receptors.
Limitations
The study had a limited number of samples from primary tumors, which may affect the assessment of oestrogen receptor content.
Want to read the original?
Access the complete publication on the publisher's website